KF006-HTC1
Basic Information
Sample Name: KF006-HTC1
Subject ID: 407
Cell Type: PE enriched SARS-CoV-2 Spike+ B cells
Tissue Source: Blood
Condition: SLE
Treatment: Belimumab
Collection Date: 2024-07-09
Processing Date: 2024-05-28
Cell Ranger Quality Metrics
3,000
Cells Loaded
5
Cells Mapped
5
Cells Kept
0.2%
Mapping Rate
(Mapped / Loaded)100.0%
Retention Rate
(Kept / Mapped)Study-Specific Information
Sex: Female
Age: 53
Race: aa
Hashtag: HTC1
Number of Vaccinations: 2
Days Post-Vaccination: 184
Vaccine Type: pfizer
Associated Assays
Quality Status:
Shows QC results for this sample in each assay.
Pending = awaiting review,
Passed = meets QC criteria,
Failed = below QC thresholds,
Flagged = needs attention.
Click the dropdown to update status.
| Assay Name | Type | Study | Position | Index Barcode | Quality Status |
|---|---|---|---|---|---|
| KF006-scRNA-seq | scRNA-seq | EXP2 | - | - | |
| KF006-CITE-seq | CITE-seq | EXP2 | - | - | |
| KF006-scVDJ-seq | scVDJ-seq | EXP2 | - | - |
Sample Timeline
Created:
2025-09-03 14:21 UTC
2025-09-03 14:21 UTC
Collected:
2024-07-09
2024-07-09
Processed:
2024-05-28
2024-05-28
Last Updated:
2025-11-20 16:43 UTC
2025-11-20 16:43 UTC